OXB · 13 hours ago
Associate Director, MSAT
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. The Associate Director, MSAT will own process lifecycle management, technology transfer execution, and continuous process improvement to ensure robust, compliant, and scalable manufacturing processes throughout commercial operations.
BiotechnologyGeneticsTherapeutics
Responsibilities
Own and execute MSAT and tech transfer strategy aligned with site and company objectives
Proactively interfaces with internal and external groups to ensure project objectives and activities align
Lead end-to-end technology transfers from development to commercial manufacturing and between sites
Serve as technical expert for commercial process performance, deviations, CAPAs, and change control
Drive process improvement, optimization, and lifecycle management across upstream, downstream, and fill-finish
Build and develop a high-performing MSAT team, fostering scientific rigor and accountability
Establish and mature MSAT systems, standards, and governance in a GMP environment
Support inspection readiness and regulatory interactions
Qualification
Required
Bachelor's degree in Biochemistry, Chemical Engineering, or related field (advanced degree preferred)
10+ years biopharmaceutical MSAT or manufacturing experience, including commercial stage operations
Direct experience with AAV and/or LVV manufacturing and GMP knowledge
Proven leadership of tech transfers and cross-functional teams and can work in a fast-paced, highly collaborative environment
Hands-on experience in process characterization using quality-by-design (QbD) principles
Ability to influence, motivate, and drive technical rigor in direct reports
Previous experience working with CDMOs and/or cGMP manufacturing
Willingness to travel domestically and internationally (up to 15%)
Benefits
Competitive total reward packages
Wellbeing programs that support your mental and physical health
Career development opportunities to help you grow and thrive
Supportive, inclusive, and collaborative culture
State-of-the-art labs and manufacturing facilities
Company
OXB
OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
Funding
Current Stage
Public CompanyTotal Funding
$217.05MKey Investors
Oaktree Capital ManagementSerum Institute of India Pvt. Ltd.
2025-08-01Post Ipo Debt· $60M
2021-09-22Post Ipo Equity· $68.08M
2019-05-01Post Ipo Equity· $69.83M
Recent News
2026-01-16
2026-01-16
2026-01-16
Company data provided by crunchbase